Kevin Rakszawski
Overview
Explore the profile of Kevin Rakszawski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rao P, Segel J, Bingen K, Devine K, Scott A, Koehly L, et al.
J Health Psychol
. 2025 Jan;
:13591053241311977.
PMID: 39887965
Adolescent/young adult cancer survivors (AYACS) are diagnosed with cancer between 15 and 39 years of age. Improving AYACS' survivorship quality is crucial-including improving social connectedness, a construct describing the quality,...
2.
Zhang R, Shang Y, Cioccio J, Rakszawski K, Nickolich M, Ehmann C, et al.
J Mol Diagn
. 2024 Nov;
26(12):1159-1170.
PMID: 39603755
Chimerism test was evaluated to predict leukemia relapse. Increasing mixed chimerism (IMC), defined as recipient increase ≥0.1% in peripheral blood total cell chimerism, was used as a surrogate of disease...
3.
Khosla A, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.
Blood Transfus
. 2024 Oct;
22(6):525-528.
PMID: 39447189
No abstract available.
4.
Rao P, Segel J, Bingen K, Devine K, Rumbaugh C, Costigan H, et al.
Support Care Cancer
. 2024 Aug;
32(9):572.
PMID: 39105828
Purpose: Adolescent and young adult cancer survivors (AYACS) are patients diagnosed with cancer between 15 and 39 years of age. AYACS are often derailed from planned educational and occupational endeavors...
5.
Zulch E, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, et al.
Leuk Res
. 2024 Jun;
143:107530.
PMID: 38852515
Primary graft failure (PGF) and multi-lineage cytopenia (MLC) increase the risk of nonrelapse mortality in allogeneic hematopoietic cell transplants (HCT). We evaluated the impact of post-transplant cyclophosphamide (PTCy) and splenomegaly...
6.
Guare E, Hale C, Sivik J, Lehman E, Inoue Y, Rakszawski K, et al.
Transpl Infect Dis
. 2024 Jan;
26(2):e14241.
PMID: 38269469
Background: Bacterial prophylaxis with a fluoroquinolone (FQ) during autologous stem cell transplant (ASCT) is common, although not standardized among transplant centers. The addition of doxycycline (doxy) to FQ prophylaxis was...
7.
Naik S, Rakszawski K, Zheng H, Claxton D, Minagawa K, Mineishi S
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256031
Acute myeloid leukemia patients with induction failure or relapsed refractory disease have minimal chance of achieving remission with subsequent treatments. Several trials have shown the feasibility of clofarabine-based conditioning in...
8.
Potiaumpai M, Schmitz K, Mineishi S, Naik S, Wirk B, Rakszawski K, et al.
BMJ Open
. 2023 Jan;
13(1):e066841.
PMID: 36657760
Introduction: Haematopoietic stem cell transplant (HSCT) in adults is an intensive medical procedure for a variety of haematological malignancies. Although there is a large body of evidence demonstrating the negative...
9.
Cioccio J, Rakszawski K, Zheng H, Nickolich M, Naik S, Wirk B, et al.
Ann Hematol
. 2022 Dec;
102(3):613-620.
PMID: 36527460
Full donor T-cell chimerism (FDTCC) after allogeneic stem cell transplant (allo-SCT) has been associated with improved outcomes in hematologic malignancy. We studied if donor human leukocyte antigen (HLA) mismatch improves...
10.
Shah N, Cioccio J, Rakszawski K, Zheng H, Nickolich M, Naik S, et al.
Leuk Res
. 2022 Oct;
123:106969.
PMID: 36306723
No abstract available.